Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $89,618.75 -2.69%
  • Ethereum $3,033.38 -4.13%
  • BNB $886.35 -1.89%
  • Optimism $0.30 -5.65%
  • Arbitrum $0.20 -5.76%
  • Solana $133.35 -3.88%
  • Polygon $0.22 +2.77%
  • Cosmos $2.20 -4.73%
  • Avalanche $13.28 -8.04%
  • Bitcoin $89,618.75 -2.69%
  • Ethereum $3,033.38 -4.13%
  • BNB $886.35 -1.89%
  • Optimism $0.30 -5.65%
  • Arbitrum $0.20 -5.76%
  • Solana $133.35 -3.88%
  • Polygon $0.22 +2.77%
  • Cosmos $2.20 -4.73%
  • Avalanche $13.28 -8.04%
Home / ORIC Pharmaceuticals / investors

ORIC Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
6
21
ORIC Pharmaceuticals is funded by 21 investors. Pfizer and ArrowMark Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Yes Post-IPO Equity
ArrowMark Partners Yes Series D
Invus Yes Series D
Casdin Capital - Series D
City Hill Ventures - Series D
Correlation Ventures - Series D
EcoR1 Capital - Series D
Fidelity Management and Research Company - Series D
Foresite Capital - Series D
Hartford HealthCare Endowment - Series D
Irving Investors - Series D
Kravis Investment Partners - Series D
Memorial Sloan - Kettering Cancer Center - Series D
OrbiMed - Series D
Taiho Ventures - Series D
The Column Group - Series D
Topspin Partners - Series D
NS Investment - Series C
Topspin Fund - Series C
Trinitas Capital - Series C
Kohlberg Kravis Roberts - Series B

Contact

South San Francisco,California,United States
(650)388-5600
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions